Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-23

Clinical Trial Update: Erwinase Master Treatment Protocol

View source ↗

Summary

This update notes that the Erwinase master treatment protocol for acute lymphoblastic leukemia is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erwinase (L-asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Phoenix Children's Hospital | Conditions: Leukemia, Acute Lymphoblastic, Acute Lymphoid Leukemia | Status: NO_LONGER_AVAILABLE